-
Spectrum, Viropro to develop biosimilar
IRVINE, Calif. — A U.S. biotech company plans to develop a biosimilar of a monoclonal antibody used to treat cancers and autoimmune disorders.
Spectrum Pharmaceuticals announced Wednesday a deal with Viropro to develop a biosimilar rituximab, marketed under the brand name Rituxan by Roche’s Genentech division. Global sales of rituximab in 2009 were $5.6 billion, according to Spectrum.
-
Oregon, Gaiam partner on wellness products at electronics show
LAS VEGAS — Oregon Scientific and Gaiam on Wednesday announced a new wellness-bent product offering that includes low-profile heart-rate monitors with touchscreen technology; USB-powered air sanitizers; massagers for the head, back and body; and ultrasonic diffusers and heated candles for aromatherapy, which will be introduced first to buyers attending the Consumer Electronics Show.
Each product in the line will include a Gaiam Wellness DVD that features such yoga instructors as Rodney Yee providing a comprehensive approach to stress-free living.